Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
32
PRGO Quote, Financials, Valuation and Earnings
Last price:
$25.73
Seasonality move
:
2.88%
Day range:
$25.55 - $26.13
52-week range:
$23.89 - $34.60
Dividend yield:
4.29%
P/E ratio:
--
P/S ratio:
0.80x
P/B ratio:
0.77x
Volume:
2.4M
Avg. volume:
1.4M
1-year change:
-16.64%
Market cap:
$3.5B
Revenue:
$4.7B
EPS (TTM):
-$1.17
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
$1.1B | $0.81 | 3.85% | 711.98% | -- |
|
ALKS
Alkermes PLC
|
$380.6M | $0.71 | 1.1% | 13.18% | $34.08 |
|
ITRM
Iterum Therapeutics PLC
|
-- | -$0.21 | -- | -49.47% | -- |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$1B | $5.50 | 4.77% | 311.88% | $181.05 |
|
MCKPF
Mallinckrodt PLC
|
-- | -- | -- | -- | -- |
|
MDT
Medtronic PLC
|
$8.3B | $1.25 | 2.97% | 37.4% | $96.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
$25.75 | -- | $3.5B | -- | $0.28 | 4.29% | 0.80x |
|
ALKS
Alkermes PLC
|
$29.71 | $34.08 | $4.8B | 15.24x | $0.00 | 0% | 3.35x |
|
ITRM
Iterum Therapeutics PLC
|
$1.77 | -- | $29.3M | -- | $0.00 | 0% | 33.79x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$123.00 | $181.05 | $7.4B | 17.32x | $0.00 | 0% | 2.04x |
|
MCKPF
Mallinckrodt PLC
|
$0.12 | -- | $2.4M | -- | $0.00 | 0% | 0.00x |
|
MDT
Medtronic PLC
|
$81.03 | $96.00 | $103.9B | 24.78x | $0.70 | 3.43% | 3.22x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
51.01% | -0.407 | 132.76% | 1.55x |
|
ALKS
Alkermes PLC
|
18.27% | 1.823 | 6.38% | 2.82x |
|
ITRM
Iterum Therapeutics PLC
|
-- | 1.002 | -- | -- |
|
JAZZ
Jazz Pharmaceuticals PLC
|
59.44% | 0.892 | 90.76% | 3.24x |
|
MCKPF
Mallinckrodt PLC
|
62.86% | 0.000 | 73639.04% | 1.43x |
|
MDT
Medtronic PLC
|
36.83% | 0.411 | 24.65% | 1.17x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
$404.4M | $113.4M | -1.8% | -3.43% | 7.3% | $15.1M |
|
ALKS
Alkermes PLC
|
$315M | $104.8M | 21.26% | 26.09% | 30.74% | $73.3M |
|
ITRM
Iterum Therapeutics PLC
|
-- | -$6.2M | -- | -- | -- | -$13.1M |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$943.4M | $260.2M | 4.84% | 12.28% | 24.6% | $388M |
|
MCKPF
Mallinckrodt PLC
|
$221.1M | $51.7M | -81.47% | -287.81% | 7.91% | $118.1M |
|
MDT
Medtronic PLC
|
$5.5B | $1.6B | 5.61% | 8.54% | 21.04% | $554M |
Perrigo Co PLC vs. Competitors
-
Which has Higher Returns PRGO or ALKS?
Alkermes PLC has a net margin of -1.93% compared to Perrigo Co PLC's net margin of 24.43%. Perrigo Co PLC's return on equity of -3.43% beat Alkermes PLC's return on equity of 26.09%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC37.19% -$0.15 $9.3B ALKSAlkermes PLC83.31% $0.55 $1.6B -
What do Analysts Say About PRGO or ALKS?
Perrigo Co PLC has a consensus price target of --, signalling upside risk potential of 39.03%. On the other hand Alkermes PLC has an analysts' consensus of $34.08 which suggests that it could grow by 14.7%. Given that Perrigo Co PLC has higher upside potential than Alkermes PLC, analysts believe Perrigo Co PLC is more attractive than Alkermes PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC0 0 0 ALKSAlkermes PLC7 4 1 -
Is PRGO or ALKS More Risky?
Perrigo Co PLC has a beta of 0.517, which suggesting that the stock is 48.32% less volatile than S&P 500. In comparison Alkermes PLC has a beta of 0.492, suggesting its less volatile than the S&P 500 by 50.793%.
-
Which is a Better Dividend Stock PRGO or ALKS?
Perrigo Co PLC has a quarterly dividend of $0.28 per share corresponding to a yield of 4.29%. Alkermes PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -1178.74% of its earnings as a dividend. Alkermes PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or ALKS?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Alkermes PLC quarterly revenues of $378.1M. Perrigo Co PLC's net income of -$21M is lower than Alkermes PLC's net income of $92.4M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Alkermes PLC's PE ratio is 15.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.80x versus 3.35x for Alkermes PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.80x -- $1.1B -$21M ALKSAlkermes PLC3.35x 15.24x $378.1M $92.4M
-
Which has Higher Returns PRGO or ITRM?
Iterum Therapeutics PLC has a net margin of -1.93% compared to Perrigo Co PLC's net margin of --. Perrigo Co PLC's return on equity of -3.43% beat Iterum Therapeutics PLC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC37.19% -$0.15 $9.3B ITRMIterum Therapeutics PLC-- -$0.46 -- -
What do Analysts Say About PRGO or ITRM?
Perrigo Co PLC has a consensus price target of --, signalling upside risk potential of 39.03%. On the other hand Iterum Therapeutics PLC has an analysts' consensus of -- which suggests that it could grow by 323.73%. Given that Iterum Therapeutics PLC has higher upside potential than Perrigo Co PLC, analysts believe Iterum Therapeutics PLC is more attractive than Perrigo Co PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC0 0 0 ITRMIterum Therapeutics PLC0 0 0 -
Is PRGO or ITRM More Risky?
Perrigo Co PLC has a beta of 0.517, which suggesting that the stock is 48.32% less volatile than S&P 500. In comparison Iterum Therapeutics PLC has a beta of 2.404, suggesting its more volatile than the S&P 500 by 140.42%.
-
Which is a Better Dividend Stock PRGO or ITRM?
Perrigo Co PLC has a quarterly dividend of $0.28 per share corresponding to a yield of 4.29%. Iterum Therapeutics PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -1178.74% of its earnings as a dividend. Iterum Therapeutics PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or ITRM?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Iterum Therapeutics PLC quarterly revenues of --. Perrigo Co PLC's net income of -$21M is lower than Iterum Therapeutics PLC's net income of -$7.1M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Iterum Therapeutics PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.80x versus 33.79x for Iterum Therapeutics PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.80x -- $1.1B -$21M ITRMIterum Therapeutics PLC33.79x -- -- -$7.1M
-
Which has Higher Returns PRGO or JAZZ?
Jazz Pharmaceuticals PLC has a net margin of -1.93% compared to Perrigo Co PLC's net margin of 20.39%. Perrigo Co PLC's return on equity of -3.43% beat Jazz Pharmaceuticals PLC's return on equity of 12.28%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC37.19% -$0.15 $9.3B JAZZJazz Pharmaceuticals PLC89.42% $3.42 $10.3B -
What do Analysts Say About PRGO or JAZZ?
Perrigo Co PLC has a consensus price target of --, signalling upside risk potential of 39.03%. On the other hand Jazz Pharmaceuticals PLC has an analysts' consensus of $181.05 which suggests that it could grow by 47.2%. Given that Jazz Pharmaceuticals PLC has higher upside potential than Perrigo Co PLC, analysts believe Jazz Pharmaceuticals PLC is more attractive than Perrigo Co PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC0 0 0 JAZZJazz Pharmaceuticals PLC8 3 0 -
Is PRGO or JAZZ More Risky?
Perrigo Co PLC has a beta of 0.517, which suggesting that the stock is 48.32% less volatile than S&P 500. In comparison Jazz Pharmaceuticals PLC has a beta of 0.568, suggesting its less volatile than the S&P 500 by 43.191%.
-
Which is a Better Dividend Stock PRGO or JAZZ?
Perrigo Co PLC has a quarterly dividend of $0.28 per share corresponding to a yield of 4.29%. Jazz Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -1178.74% of its earnings as a dividend. Jazz Pharmaceuticals PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or JAZZ?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Jazz Pharmaceuticals PLC quarterly revenues of $1.1B. Perrigo Co PLC's net income of -$21M is lower than Jazz Pharmaceuticals PLC's net income of $215.1M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Jazz Pharmaceuticals PLC's PE ratio is 17.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.80x versus 2.04x for Jazz Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.80x -- $1.1B -$21M JAZZJazz Pharmaceuticals PLC2.04x 17.32x $1.1B $215.1M
-
Which has Higher Returns PRGO or MCKPF?
Mallinckrodt PLC has a net margin of -1.93% compared to Perrigo Co PLC's net margin of -5.18%. Perrigo Co PLC's return on equity of -3.43% beat Mallinckrodt PLC's return on equity of -287.81%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC37.19% -$0.15 $9.3B MCKPFMallinckrodt PLC43.74% -$1.33 $2.8B -
What do Analysts Say About PRGO or MCKPF?
Perrigo Co PLC has a consensus price target of --, signalling upside risk potential of 39.03%. On the other hand Mallinckrodt PLC has an analysts' consensus of -- which suggests that it could fall by --. Given that Perrigo Co PLC has higher upside potential than Mallinckrodt PLC, analysts believe Perrigo Co PLC is more attractive than Mallinckrodt PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC0 0 0 MCKPFMallinckrodt PLC0 0 0 -
Is PRGO or MCKPF More Risky?
Perrigo Co PLC has a beta of 0.517, which suggesting that the stock is 48.32% less volatile than S&P 500. In comparison Mallinckrodt PLC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PRGO or MCKPF?
Perrigo Co PLC has a quarterly dividend of $0.28 per share corresponding to a yield of 4.29%. Mallinckrodt PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -1178.74% of its earnings as a dividend. Mallinckrodt PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or MCKPF?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Mallinckrodt PLC quarterly revenues of $505.5M. Perrigo Co PLC's net income of -$21M is higher than Mallinckrodt PLC's net income of -$26.2M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Mallinckrodt PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.80x versus 0.00x for Mallinckrodt PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.80x -- $1.1B -$21M MCKPFMallinckrodt PLC0.00x -- $505.5M -$26.2M
-
Which has Higher Returns PRGO or MDT?
Medtronic PLC has a net margin of -1.93% compared to Perrigo Co PLC's net margin of 15.11%. Perrigo Co PLC's return on equity of -3.43% beat Medtronic PLC's return on equity of 8.54%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC37.19% -$0.15 $9.3B MDTMedtronic PLC64.94% $0.99 $77B -
What do Analysts Say About PRGO or MDT?
Perrigo Co PLC has a consensus price target of --, signalling upside risk potential of 39.03%. On the other hand Medtronic PLC has an analysts' consensus of $96.00 which suggests that it could grow by 18.48%. Given that Perrigo Co PLC has higher upside potential than Medtronic PLC, analysts believe Perrigo Co PLC is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC0 0 0 MDTMedtronic PLC11 14 1 -
Is PRGO or MDT More Risky?
Perrigo Co PLC has a beta of 0.517, which suggesting that the stock is 48.32% less volatile than S&P 500. In comparison Medtronic PLC has a beta of 0.820, suggesting its less volatile than the S&P 500 by 17.999%.
-
Which is a Better Dividend Stock PRGO or MDT?
Perrigo Co PLC has a quarterly dividend of $0.28 per share corresponding to a yield of 4.29%. Medtronic PLC offers a yield of 3.43% to investors and pays a quarterly dividend of $0.70 per share. Perrigo Co PLC pays -1178.74% of its earnings as a dividend. Medtronic PLC pays out 99.73% of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRGO or MDT?
Perrigo Co PLC quarterly revenues are $1.1B, which are smaller than Medtronic PLC quarterly revenues of $8.4B. Perrigo Co PLC's net income of -$21M is lower than Medtronic PLC's net income of $1.3B. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Medtronic PLC's PE ratio is 24.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.80x versus 3.22x for Medtronic PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.80x -- $1.1B -$21M MDTMedtronic PLC3.22x 24.78x $8.4B $1.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
